130 related articles for article (PubMed ID: 7689123)
21. Standard-dose recombinant human granulocyte colony-stimulating factor (rhG-CSF) allows safe and repeated administration of high-dose cyclophosphamide, etoposide, and cisplatin (CEP).
Ballestrero A; Ferrando F; Stura P; Puglisi M; Brema F; Patrone F
Am J Clin Oncol; 1997 Jun; 20(3):266-71. PubMed ID: 9167751
[TBL] [Abstract][Full Text] [Related]
22. Effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on respiratory burst activity of neutrophils in patients with myelodysplastic syndromes.
Ohsaka A; Kitagawa S; Yuo A; Motoyoshi K; Furusawa S; Miura Y; Takaku F; Saito M
Clin Exp Immunol; 1993 Feb; 91(2):308-13. PubMed ID: 7679062
[TBL] [Abstract][Full Text] [Related]
23. Long survival of leukemic mice by repeated combination treatment of cyclophosphamide and recombinant human granulocyte colony-stimulating factor.
Tamura M; Nomura H; Ono M; Bessho M; Hirashima K
Leukemia; 1991 Dec; 5(12):1043-9. PubMed ID: 1723131
[TBL] [Abstract][Full Text] [Related]
24. Effect of recombinant granulocyte colony-stimulating factor (rG-CSF) on chemotherapy-induced neutropenia in patients with urogenital cancer.
Kotake T; Miki T; Akaza H; Kubota Y; Nishio Y; Matsumura Y; Ota K; Ogawa N
Cancer Chemother Pharmacol; 1991; 27(4):253-7. PubMed ID: 1705488
[TBL] [Abstract][Full Text] [Related]
25. [Granulocyte function of patients on anti-cancer chemotherapy].
Okada H; Miyazaki J; Kamidono S
Nihon Hinyokika Gakkai Zasshi; 1994 Jun; 85(6):958-63. PubMed ID: 7520515
[TBL] [Abstract][Full Text] [Related]
26. Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer.
Crawford J; Ozer H; Stoller R; Johnson D; Lyman G; Tabbara I; Kris M; Grous J; Picozzi V; Rausch G
N Engl J Med; 1991 Jul; 325(3):164-70. PubMed ID: 1711156
[TBL] [Abstract][Full Text] [Related]
27. [Clinical study of recombinant human granulocyte colony-stimulating factor (RHG-CSF) on leucopenia induced by chemotherapy with CE regimen on lung cancer patients].
Shi YK; Feng FY; Sun Y
Zhonghua Nei Ke Za Zhi; 1994 Nov; 33(11):739-42. PubMed ID: 7541325
[TBL] [Abstract][Full Text] [Related]
28. Timing of recombinant human granulocyte colony-stimulating factor administration on neutropenia induced by cyclophosphamide in normal mice.
Misaki M; Ueyama Y; Tsukamoto G; Matsumura T
Br J Cancer; 1998 Mar; 77(6):884-9. PubMed ID: 9528829
[TBL] [Abstract][Full Text] [Related]
29. In vivo activation of human neutrophil functions by administration of recombinant human granulocyte colony-stimulating factor in patients with malignant lymphoma.
Ohsaka A; Kitagawa S; Sakamoto S; Miura Y; Takanashi N; Takaku F; Saito M
Blood; 1989 Dec; 74(8):2743-8. PubMed ID: 2479431
[TBL] [Abstract][Full Text] [Related]
30. Changes in white blood cells and myeloperoxidase activity in rhG-CSF prophylactic patients receiving cytotoxic chemotherapy.
Charuruks N; Krailadsiri P; Voravud N; Nitipaijit N; Srisink N; Settapiboon R
J Med Assoc Thai; 1994 Aug; 77(8):426-33. PubMed ID: 7533203
[TBL] [Abstract][Full Text] [Related]
31. Clinical trial of recombinant granulocyte colony-stimulating factor for chemotherapy-induced neutropenia patients with oral cancer.
Iwase M; Yoshiya M; Kakuta S; Nagumo M
J Oral Maxillofac Surg; 1997 Aug; 55(8):836-40; discussion 841. PubMed ID: 9251612
[TBL] [Abstract][Full Text] [Related]
32. [The effects and pharmacokinetics of rhG-CSF on the treatment of neutropenia in patients with renal failure].
Shishido K; Niikura K; Akizawa T; Koshikawa S
Nihon Jinzo Gakkai Shi; 1991 Oct; 33(10):973-81. PubMed ID: 1722829
[TBL] [Abstract][Full Text] [Related]
33. A study of dose escalation of teniposide (VM-26) plus cisplatin (CDDP) with recombinant human granulocyte colony-stimulating factor (rhG-CSF) in patients with advanced small cell lung cancer.
Eguchi K; Etou H; Miyachi S; Morinari H; Nakada K; Noda K; Ohkuni Y; Watanabe K; Yamada Y; Ohe Y
Eur J Cancer; 1994; 30A(2):188-94. PubMed ID: 7512356
[TBL] [Abstract][Full Text] [Related]
34. Dose-intensification of MVAC with recombinant granulocyte colony-stimulating factor as initial therapy in advanced urothelial cancer.
Seidman AD; Scher HI; Gabrilove JL; Bajorin DF; Motzer RJ; O'Dell M; Curley T; Dershaw DD; Quinlivan S; Tao Y
J Clin Oncol; 1993 Mar; 11(3):408-14. PubMed ID: 7680373
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetic/pharmacodynamic analysis of neutrophil proliferation induced by rhG-CSF in patients receiving antineoplastic drugs.
Sugiura M; Ohno Y; Yamada Y; Suzuki H; Iga T
Yakugaku Zasshi; 2004 Sep; 124(9):599-604. PubMed ID: 15340181
[TBL] [Abstract][Full Text] [Related]
36. [Effect of recombinant human granulocyte colony stimulating factor in patients with transitional cell carcinoma of the urothelium receiving methotrexate, etoposide and cisplatinum combination chemotherapy].
Miura T; Murai T; Shimura H; Kondo I
Hinyokika Kiyo; 1993 Mar; 39(3):209-12. PubMed ID: 7685138
[TBL] [Abstract][Full Text] [Related]
37. Granulocyte colony-stimulating factor (G-CSF) prevents dose-limiting neutropenia in lymphoma patients receiving standard dose chemotherapy.
Dotti G; Stella CC; Mangoni L; Cottafavi L; Caramatti C; Almici C; Rizzoli V
Haematologica; 1995; 80(2):142-5. PubMed ID: 7543069
[TBL] [Abstract][Full Text] [Related]
38. Treatment of chemotherapy-induced neutropenia in children with subcutaneously administered recombinant human granulocyte colony-stimulating factor.
Okamura J; Yokoyama M; Tsukimoto I; Komiyama A; Sakurai M; Imashuku S; Miyazaki S; Ueda K; Hanawa Y; Takaku F
Pediatr Hematol Oncol; 1992; 9(3):199-207. PubMed ID: 1381941
[TBL] [Abstract][Full Text] [Related]
39. [Clinical studies of recombinant human granulocyte colony-stimulating factor in elderly patients with malignant lymphoma].
Arai N; Hara A; Kaneko H; Umeda M; Shirai T
Nihon Ronen Igakkai Zasshi; 1992 May; 29(5):385-9. PubMed ID: 1380571
[TBL] [Abstract][Full Text] [Related]
40. Schedule-intensified M-VAC chemotherapy for advanced urothelial cancer with recombinant human granulocyte colony stimulating factor (rhG-CSF).
Noguchi S; Kubota Y; Shuin T; Hosaka M; Miura T; Kondoh I
Int J Urol; 1994 Jun; 1(2):140-2. PubMed ID: 7543010
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
